We look at the cutting-edge injectable hydrogel that delivers long lasting, proven pain relief for knee osteoarthritis without surgery (1-2)

For many of the 8.5 million people in the UK living with knee osteoarthritis (OA), (3) life is hampered by constant pain, limited mobility, and difficulty with simple, everyday tasks. But there’s hope with Arthrosamid® – a permanent injectable hydrogel (4) that delivers long-lasting, proven pain relief without surgery (1-2) - redefining treatment for knee OA, with experts calling it a ‘game-changer.’

People delay seeking help for knee pain, assuming it’s an unavoidable part of ageing. But Arthrosamid® offers patients a new pathway. Supported by more than two decades of research, (5) Arthrosamid® is suitable, safe and effective (1,2,6-10) for most patients with knee OA, administered via a simple, one-step procedure under local anaesthetic and gives a significant, long-lasting reduction in knee OA pain – even four years post-treatment. (1) 

(Image: Arthrosamid®)

What the experts say

Mr Chan Jeer, a consultant trauma and orthopaedic surgeon at One Ashford and KIMS Hospital, both based in the Kent area offering the Arthrosamid® treatment, says: ‘The evidence for Arthrosamid® offers patients the potential for significant reduction in pain, as well as improvements in their mobility, and overall quality of life.

‘In contrast to other treatments, Arthrosamid® appears to be offering patients longer-lasting respite from the pain and immobility of knee osteoarthritis and, in many cases, avoiding or delaying the need for surgery. I believe it’s setting a real benchmark in the area of orthopaedics, offering hope and optimism to many of those living with this condition.’

To find your nearest clinic offering the Arthrosamid® treatment, please visit arthrosamid.com/find-a-clinic or email enquiries@arthrosamid.com. For more information about Arthrosamid®, please visit arthrosamid.com

References:

  1. Bliddal, H., et al. (2024) A Prospective Study of Polyacrylamide Hydrogel Injection for Knee Osteoarthritis: Results From 4 Years After Treatment. Presented at EORS 2024.
  2. Bliddal, H., et al. (2024) 3-year follow-up from a randomized controlled trial of intra-articular polyacrylamide hydrogel injection in subjects with knee osteoarthritis. Poster LB-31, OARSI 2024 World Congress on Osteoarthritis.
  3. nice.org.uk/guidance/cg177/documents/osteoarthritis-update-final-scope2
  4. Christensen, L., et al. (2016). Histological Appearance of the Synovial Membrane after Treatment of Knee Osteoarthritis with Polyacrylamide Gel Injections: A Case Report. Journal of Arthritis. Vol 5: 217.
  5. Data on file
  6.  Bliddal, H., et al. (2021) Polyacrylamide Hydrogel Injection for Knee Osteoarthritis: A 6 Months Prospective Study. J Orthop Res Ther. Vol 6 (2). 1188. ISSN 2575-8241
  7. Bliddal, H., Beier, J., Hartkopp, A. et al. Effectiveness and safety of polyacrylamide hydrogel injection for knee osteoarthritis: results from a 12-month follow up of an open-label study. J Orthop Surg Res 19, 274 (2024).
  8. Bliddal, H., et al. (2022). A Prospective Study of Polyacrylamide Hydrogel Injection for Knee Osteoarthritis: Results From 2 Years After Treatment. Poster presented at OARSI 2022. Osteoarthritis and Cartilage. Vol 30(1): S371-S372. DOI:10.1016/j.joca.2022.02.499.
  9. Bliddal, H., et al. (2023) A Prospective Study of Polyacrylamide Hydrogel Injection for Knee Osteoarthritis: Results From 3 Years After Treatment. Osteoarthritis and Cartilage. Vol 31(5): 682-683.
  10. Bliddal, H., et al. (2022). One-year performance of polyacrylamide hydrogel vs. hyaluronic acid: A randomised controlled study. Osteoarthritis and Cartilage, Vol 30, S1, S371.